European Commission
Cancer Mission Clinical Research on Lung, Bowel, Breast or Prostate Cancer
Call identifier HORIZON-MISS-2027-02-CANCER-02; no submission deadline stated on page
Last updated:
No deadline is on file for this call. Check European Commission's own call page for the current round's status before you plan around it.
The European Commission's Cancer Mission Clinical Research on Lung, Bowel, Breast or Prostate Cancer funds multi-centre clinical trials and implementation projects led by comprehensive cancer infrastructures across Europe. Projects must build 3+ entity consortia spanning at least 3 EU member states, with pilot or scale-up in at least 4 countries including one with limited cancer infrastructure. The call covers innovative diagnostics, radiotherapy, chemotherapy, surgery, therapeutic vaccines, and guideline implementation, all anchored in patient co-design and open science through the UNCAN.eu platform.
Details
| Funder | European Commission |
| Consortium | Required — minimum 3 entities from 3 EU member states; additionally, comprehensive cancer infrastructures must pilot/upscale in at least 4 different EU Member States or Associated Countries, including one with limited cancer infrastructure |
Eligibility & scope
Supports clinical research on lung, bowel, breast or prostate cancer conducted by comprehensive cancer infrastructures across EU Member States and Associated Countries. Covers innovative diagnostics, radiotherapy/surgery/chemotherapy, therapeutic cancer vaccines, and guideline implementation. Requires multi-stakeholder consortia, patient co-design, sex/gender-disaggregated data, and open science compliance via UNCAN.eu. Successful projects join the EU Cancer Mission 'Diagnosis and Treatment' cluster.
Who Should Apply
- •Comprehensive cancer infrastructure centres or networks with established clinical research capacity
- •Institutions willing to build consortia of 3+ entities across 3+ EU/Associated countries
- •Research teams piloting or scaling innovations in diagnostics, surgery, radiotherapy, chemotherapy or therapeutic vaccines
- •Centres committing to patient co-design, sex/gender-disaggregated data collection, and UNCAN.eu open science compliance
- •Projects addressing underserved regions or countries with limited cancer infrastructure
Key Dates
- •Call identifier: HORIZON-MISS-2027-02-CANCER-02 (consult Funding and Tenders portal for submission deadline)
- •Multi-stage evaluation including consortium feasibility assessment
- •Successful projects join the EU Cancer Mission 'Diagnosis and Treatment' cluster
Tips for Applicants
- ✓Consortium governance is non-negotiable, demonstrate clear roles for each of your 3+ partners and name a lead centre; vague 'networks' without formal agreements score poorly.
- ✓Patient co-design is mandatory, not optional; include patient representatives in your steering group and describe their involvement in study design and dissemination.
- ✓Explicit plans to include a centre in a country with limited cancer infrastructure will differentiate your proposal; do not leave this to chance.
Frequently Asked Questions
What cancers can I apply for under the Cancer Mission Clinical Research call?
The call funds projects on lung, bowel, breast, or prostate cancer conducted by comprehensive cancer infrastructures across EU member states and associated countries.
How many partners do I need for the Cancer Mission Clinical Research call?
A minimum of 3 entities from 3 different EU member states, and your consortium must pilot or scale-up in at least 4 different EU member states or associated countries, including one with limited cancer infrastructure.
What types of research does the Cancer Mission Clinical Research call fund?
Innovative diagnostics, radiotherapy, surgery, chemotherapy, therapeutic cancer vaccines, and guideline implementation, all conducted within comprehensive cancer infrastructure networks.
Is patient involvement required in the Cancer Mission Clinical Research call?
Yes, projects must include patient co-design and collect sex/gender-disaggregated data as part of the multi-stakeholder approach mandated by the call.
Related on Grantsby
- European Commission writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Capacity-building programme for Comprehensive Cancer Infrastructures
European CommissionCancer Mission Ria – Horizon-Miss-2026-02-Cancer-02
European CommissionDeadline: 15 Sept 2026Around €15MCancer Mission Innovation Action – HORIZON-MISS-2026-02-CANCER-05
European CommissionDeadline: 15 Sept 2026Around €7MCancer Mission Coordination and Support Action – HORIZON-MISS-2026-02-CANCER-06
European CommissionDeadline: 15 Sept 2026Around €5MMicrobiome tools for cancer prevention and early detection
European Commission
Browse Related
Could Cancer Mission Clinical Research on Lung, Bowel, Breast or Prostate Cancer be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →